CCMI
SRPT icon

Creative Capital Management Investments’s Sarepta Therapeutics SRPT Stock Holding History

Creative Capital Management Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72 Buy
+4
New +$76 ﹤0.01% 1431

Other funds holding SRPT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Creative Capital Management Investments's SRPT Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 4 shares worth $72. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings.

49 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Creative Capital Management Investments held 4 shares of Sarepta Therapeutics worth $72 as of Q2 2026.
  • Sarepta Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1431 holding.
  • 49 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.